site 28 in situ abiotic/biotic treatability study implementation
DESCRIPTION
Presentation to the Moffett Restoration Advisory Board November 18, 2010: Site 28 In Situ Abiotic/Biotic Treatability Study ImplementationTRANSCRIPT
Installation Restoration Site 28
In Situ Abiotic / Biotic Treatability StudyI l t tiImplementation
RAB Meeting November 18 2010November 18, 2010
Former Naval Air Station Moffett Field, Moffett Field, California
Site 28 Area
2
IR Site 28 Treatability Study
Purpose of Treatability Study (TS)Determine if in situ anaerobic biotic or combined abiotic/biotic treatment technologies are viable for remediating the remaining chlorinated ethenes (CEs) present in the upper and g ( ) p pplower portions of the A-aquifer at IR Site 28.
Treatability Study MethodConduct separate pilot tests in areas of highest CE concentrations at three areas of interest (Former Building 88, Traffic Island, and Well W9-18).
Stage 1: Hot Spot Characterization
Stage 2: Treatment Pilot Tests
Stage 1: Hot Spot Characterization
Hot Spot DelineationHot Spot DelineationFurther define lateral and vertical distribution of high concentration chlorinated ethenes (CEs) in the three areas of interest.
Dense Non-Aqueous Phase Liquid (DNAPL) InvestigationEvaluate whether PCE DNAPLs are present in the Former Building 88 Area and Traffic Island Area
Stage 2: Treatment Pilot Tests
Evaluate Two Processes/Three Treatment Technologies Separately:Separately:
In Situ Anaerobic Biostimulation with Bioaugmentation Process
Sodium Lactate (Wilclear®) & Dechlorinating Microbial Consortium (SDC-9™)Sodium Lactate (Wilclear ) & Dechlorinating Microbial Consortium (SDC 9 )
Emulsified Vegetable Oil (LactOil™) & SDC-9™
In Situ Anaerobic Biotic/Abiotic Degradation Process
Zero-valent iron with controlled-release carbon (EHC®)
Concurrent Pilot Tests in Three High Concentration Areas:
Traffic Island Area (LactOil™ & SDC-9™)
Building 88 Area (Wilclear® & SDC-9™)
Well W9-18 Area (EHC®)
Site 28 Pilot Test Area
6
ISABB - Emulsified OilISABB - Emulsified Oil & SDC-9™
ISABA - EHC®
ISABB - Lactate & SDC-9™
IR Site 28 Treatability Study Implementation
Stage 1: Hot Spot CharacterizationStage 1: Hot Spot Characterization
March and April 2010p
Hot Spot Delineation
DNAPL Investigation
Hot Spot Delineation
Goal: Further define lateral and vertical distribution ofGoal: Further define lateral and vertical distribution of high concentration chlorinated ethenes (CEs)
• Membrane Interface Probe (MIP) Testing
o Total depth of 65 feet below ground surface
o 19 locations in Traffic Island Area
o 12 locations in Former Building 88 Area
o 4 locations in Well W9-18 Area
MIP Test Locations
Membrane Interface Probe (MIP)
11
MIP Installation
12
MIP Installation
13
Typical MIP Log
14
ECD PID FID
DNAPL Investigation
Goal: Evaluate for the potential presence of PCE DNAPLs in the Former Building 88 Area and Traffic Island Area
• Continuous Soil Cores
o Adjacent to MIP test with greatest detector responses
o Visual observation and PID scanning
o Select OilScreenSoil (Sudan IV)® Screening Tests
• H d h bi Fl ibl M b T ti• Hydrophobic Flexible Membrane Testingo NAPL FLUTeTM Liner
o Adjacent to continuous soil coreso Adjacent to continuous soil cores
• 1 location in Former Bldg 88 Area; 2 locations in Traffic Island Area
• Maximum depth of 65 feet below ground surface
• No evidence of DNAPLs encountered
Soil Core & NAPL FLUTe™ Test Locations
OilScreenSoil (Sudan IV)® Test
17
NAPL FLUTe™ Liner
18
NAPL FLUTe™ Liner Deployment
19
NAPL FLUTe™ Liner Dilation
20
NAPL FLUTe™ Liner Removal
21
NAPL FLUTe™ - Protective Liner Removal
22
NAPL FLUTe™ Liner Inspection – No Staining
23
Emulsified Oil & SDC-9™Emulsified Oil & SDC 9
EHC®
Lactate & SDC-9™
Observation Well Network &Observation Well Network & Injection Grid Layout
Former Building 88 Area Cross-Section
GW flow direction
Well W9-18 Area Cross-Section
GW flow directionGW flow direction
Traffic Island Area Cross-Section
GW flow direction
IR Site 28 Treatability Study Implementation
Stage 2: Treatment Pilot TestsStage 2: Treatment Pilot Tests
July and August 2010y g
Observation Well Network Installation
Baseline Groundwater Monitoring Event
Substrate Preparation
Substrate Injection Substrate Injection
Post-Injection Performance Monitoring
Observation Well Network Installation – June 2010
29
Well Installation – Traffic Island
30
Baseline Groundwater Monitoring Event - July 2010
31
Monitoring Parameters
• VOC• VOCs
PCE, TCE, DCE, VC, Ethene, Ethane, Acetylene
• Bi h i l I di t• Biogeochemical Indicators DO, Nitrate, Arsenic, Manganese, Iron, Sulfate, Methane
• Organic Substrate Indicators• Organic Substrate Indicators
TOC, Alkalinity, and Volatile Fatty Acids
• Physical• PhysicalpH, ORP, Specific Conductance, Turbidity, Temperature
• BiologicalBiologicalDehalococcoides sp
Bldg 88 Area - Total Chlorinated Ethenes, µg/L
GW flow direction
27 279 3 002 3 04927,279 3,002 3,049
4,306 3,764 4,521
Traffic Island Area - Total Chlorinated Ethenes, µg/L
GW flow direction
8724,1091,759
751469476
18,2453,614311
3432,9504,62336,125
Well W9-18 Area - Total Chlorinated Ethenes, µg/L
GW flow direction
3,158 6,375 3,049
2,381 2,727 7,816
35
Substrate Mixing Tank – Former Bldg 88 Area
36
Substrate Preparation
37
Substrate Mixing Tank – Traffic Island Area
38
Bioaugmentation
Addition of dechlorinatingi bi l ti t b t hmicrobial consortium to batch
mixing tank
Shaws Patented SDC-9™Shaws Patented SDC 9
Contains Dehalococcoides sp
Naturally occurring microbes (not engineered)
Injected at hundreds of sitesInjected at hundreds of sites
Native to California
39
Injected at Former Building 88 Area and Traffic Island Area
Batch Tank – Traffic Island Area
Substrate Injection
Substrate Injection – Traffic Island
42
Substrate Injection Rigs
43
Substrate Injection – Traffic Island
44
Substrate Injection Tool
Pressure Activated Injection
Wilclear® & SDC-9™ Injection – Former Bldg 88 Area
• Original estimated sodium lactate demand for t t t 1 060 lb (i l 4 ti f t f t )treatment area ~1,060 lbs (incl. 4 times safety factor)
• Due to anticipated high pH replaced 184 lbs of lactate i h 55 lb f l i idwith 55 lbs of lactic acid
• 876 lbs of lactate with 55 lbs of lactic acid injected
• ~8,000 gallons of pre-treated GW from WATS injected
• 34 L of SDC-9 injected to generate a target concentration of 1x107 cells DHC/liter
• 10 points, 35 to 60 ft bgs
Injection Layout – Former Bldg 88 Area
LactOil™ & SDC-9™ Injection – Traffic Island Area
• Target concentration of 8 000 mg/L emulsifiedTarget concentration of 8,000 mg/L emulsified vegetable oil in GW
• 3 190 gallons of LactOil™ injected3,190 gallons of LactOil injected
• ~28,000 gallons of pre-treated GW from WATS injected
• 119 L of SDC-9™ injected to generate a target concentration of 1x107 cells DHC/liter
• 15 points, 10 to 65 ft bgs
Injection Layout – Traffic Island Area
10 to 55 ft bgs intervalg
Injection Layout – Traffic Island Area
55 to 65 ft bgs intervalg
EHC® Injection – Well W9-18 Area
• Original target ~0.3% of EHC® by soil massOriginal target 0.3% of EHC by soil mass (~4,000 lbs EHC®)
• Doubled the dose to ~8,000 lbs EHC® based onDoubled the dose to 8,000 lbs EHC based on IR Site 26 results
• ~8 000 lbs of EHC® injected~8,000 lbs of EHC® injected
• ~2,500 gallons of hydrant water injected
• No bioaugmentation with SDC-9™
• 4 points 10 to 30 ft bgs• 4 points, 10 to 30 ft bgs
Injection Layout – Well W9-18 Area
Post-Injection
Performance Groundwater Monitoring
• 5 post–injection events:
g
p j August 2010
early November 2010
late January 2010
mid April 2011
late June 2011
•All 24 observation wells + 3 monitoring wells
•Same analytical parameters as baseline event VOCs, Biogeochemical Indicators, Organic Substrate Indicators, Physical, and Biological
pH in Treatability Study Areas
W9-18Bldg 88Traffic Island
Treatability Study Wells
10.010.511.0
HTraffic Island - Emulsified Oil
pH
28OW-13
28OW-14
28OW-15
28OW-01 28OW-02
28OW-03 28OW-04
28OW-05 28OW-067.58.08.59.09.5
dard
Uni
ts fo
r pH
28OW-16
28OW-17
28OW-18
28OW-07 28OW-08
28OW-09 28OW-10
28OW-11 28OW-125.05.56.06.57.0
Stan
d
W9-18W9-29 W9-42
W9-18 Area - EHC®pH
8 0
Building 88 - LactatepH
0 20 40 60 80 100Days (Day 0 = August 16, 2010)
10
11
12
or p
H
p
7.0
7.5
8.0
s fo
r pH
7
8
9St
anda
rd U
nits
fo
5 5
6.0
6.5
Stan
dard
Uni
ts
5
6
0 20 40 60 80 100
S
Days (Day 0 = August 24, 2010)
5.0
5.5
0 20 40 60 80 100 120Days (Day 0 = August 2, 2010)
ORP in Treatability Study Areas
W9-18Bldg 88Traffic Island
Treatability Study Wells200
300
Traffic Island - Emulsified OilOxidation-Reduction Potential
28OW-13
28OW-14
28OW-15
28OW-01 28OW-02
28OW-03 28OW-04
28OW-05 28OW-06-100
0
100
mill
iVol
ts
28OW-16
28OW-17
28OW-18
28OW-07 28OW-08
28OW-09 28OW-10
28OW-11 28OW-12-400
-300
-200
W9-18W9-29 W9-42
W9-18 Area - EHC®Oxidation-Reduction Potential
300
Building 88 - LactateOxidation-Reduction Potential
0 20 40 60 80 100Days (Day 0 = August 16, 2010)
100
200
300
olts
100
200
300
olts
-200
-100
0m
illiV
o
-200
-100
0
mill
iVo
56
-400
-300
0 20 40 60 80 100Days (Day 0 = August 24, 2010)
-400
-300
0 20 40 60 80 100 120Days (Day 0 = August 2, 2010)
DO in Treatability Study Areas
W9-18Bldg 88Traffic Island
Treatability Study Wells
2.0
2.5
g/L)
Traffic Island - Emulsified OilDissolved Oxygen
28OW-13
28OW-14
28OW-15
28OW-01 28OW-02
28OW-03 28OW-04
28OW-05 28OW-061.0
1.5
once
ntra
tion
(mg
28OW-16
28OW-17
28OW-18
28OW-07 28OW-08
28OW-09 28OW-10
28OW-11 28OW-120.0
0.5
Co
W9-18W9-29 W9-42
W9-18 Area - EHC®Dissolved Oxygen
1 8
Building 88 ‐ LactateDissolved Oxygen
0 20 40 60 80 100Days (Day 0 = August 16, 2010)
2.5
3.0
3.5
(mg/
L)1.2
1.4
1.6
1.8
(mg/L)
1.0
1.5
2.0
Con
cent
ratio
n (
0.4
0.6
0.8
1.0
Concen
tration
57
0.0
0.5
0 20 40 60 80 100Days (Day 0 = August 24, 2010)
0.0
0.2
0 20 40 60 80 100 120Days (Day 0 = August 2, 2010)
Questions ?